Cambrex $425 million acquisition of Halo Pharma

23/7/2018

Private acquisition

Value:

$ 425 million

Status:

Announced

Date:

23/7/2018

Overview:

Cambrex has acquired Halo Pharma from the private investment firm SK Capital.
RBC Capital Markets acted as financial adviser to Cambrex, while Wells Fargo Securities and Mizuho Securities advised Halo Pharma.
The deal is expected to close in the third quarter of 2018.

Mihail Georgiev - Data analyst

Jurisdiction:

United States

Deal type:

Private acquisition

Practice area:

M&A

Governing law:

United States

Industry sector:

Pharmaceuticals and life sciences

Firms:

Morgan Lewis & Bockius

Party: Halo Pharma Inc (Target)

Lawyers: Etienne Shanon, Jeannine Bishop, Steven Cohen

Ropes & Gray

Party: Cambrex Corporation (Acquirer)

Lawyer: Paul Kinsella

Related deals